Sabby Management, LLC
- SEC CIK
- 0001535610
- Latest filing
- Aug 14, 2026
Holdings in Q2 2026
Holdings as of Jun 30, 2026, filed Aug 14, 2026. Long positions only; changes compare share counts with Q1 2026.
- Positions
- 16
- −6 vs. Q1 2026
- Portfolio value
- $12.0M
- +$6.31M (+110.5%) vs. Q1 2026
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| SPYSPDR S&P 500 ETF Trust | ETF | 5,500 | $4.11M | 34.2% | +2,766+101.2% | Added | History |
| TOYOTOYO Co., Ltd | ORD SH | 503,846 | $3.50M | 29.1% | +503,846 | New | History |
| FAMIFarmmi, Inc. | SHS NEW | 3,515,929 | $840.3K | 7.0% | +3,515,929 | New | History |
| CRVOCervoMed Inc. | COM | 248,880 | $771.5K | 6.4% | +248,880 | New | History |
| TPSTTempest Therapeutics, Inc. | COM | 511,286 | $567.5K | 4.7% | +493,430+2,763.4% | Added | History |
| PAVSParanovus Entertainment Technology Ltd. | CL A ORD SHS | 75,440 | $560.5K | 4.7% | +75,440 | New | History |
| BIAFbioAffinity Technologies, Inc. | COM NEW | 365,647 | $296.9K | 2.5% | +365,647 | New | History |
| CREGSmart Powerr Corp. | COM | 127,774 | $263.2K | 2.2% | +127,774 | New | History |
| BCTXBriaCell Therapeutics Corp. | COM | 80,721 | $261.5K | 2.2% | +6,806+9.2% | Added | History |
| REVBRevelation Biosciences, Inc. | COM | 210,582 | $216.9K | 1.8% | +111,150+111.8% | Added | History |
| SNESSenesTech, Inc. | COM NEW | 141,756 | $211.2K | 1.8% | −76,777−35.1% | Reduced | History |
| BCTXLBriaCell Therapeutics Corp. | *W EXP 01/15/203 | 190,383 | $169.4K | 1.4% | −190,303−50.0% | Reduced | History |
| SIDUSidus Space Inc. | CL A COM NEW | 43,377 | $121.9K | 1.0% | +43,377 | New | History |
| INMInMed Pharmaceuticals Inc. | Common Stock | 44,970 | $69.7K | 0.6% | −175,290−79.6% | Reduced | History |
| NUWENuwellis, Inc. | COM | 16,372 | $49.9K | 0.4% | +16,372 | New | History |
| BCTXZBriaCell Therapeutics Corp. | *W EXP 99/99/999 | 120,802 | $11.5K | 0.1% | −85,951−41.6% | Reduced | History |
Options (7)
Puts and calls in the same filing. Amounts are the market value of the underlying shares, which is what 13F reports.
| Security | Class | Puts | Calls |
|---|---|---|---|
| SPDR S&P 500 ETF Tr78462F953 | PUT | $54.1M | – |
| SPDR S&P 500 ETF Tr78462F903 | CALL | – | $15.3M |
| iShares Tr464287905 | CALL | – | $13.3M |
| iShares Tr464287955 | PUT | $13.2M | – |
| Abivax SA00370M903 | SPONSORED ADS | – | $1.09M |
| Sidus Space Inc826165951 | CL A COM NEW | $816.3K | – |
| Kempharm Inc488445956 | PUT | $612.3K | – |
Sold out since Q1 2026 (14)
Positions held at the end of Q1 2026 that are gone from this filing.
| Security | Class | Shares in Q1 2026 | Value in Q1 2026 | % of portfolio in Q1 2026 | History |
|---|---|---|---|---|---|
| ALPAlpha Compute Corp | SHS NEW | 2,072,103 | $654.8K | 11.5% | History |
| DSYBig Tree Cloud Holdings Ltd | SHS CL A | 137,611 | $337.1K | 5.9% | History |
| TCToken Cat Ltd | ADS | 23,239 | $241.7K | 4.2% | History |
| CPOPPop Culture Group Co., Ltd | SHS NEW | 664,449 | $201.1K | 3.5% | History |
| MBRXMoleculin Biotech, Inc. | COM | 75,021 | $171.8K | 3.0% | History |
| BDRXBiodexa Pharmaceuticals Plc | ADR | 257,472 | $159.1K | 2.8% | History |
| RKDAArcadia Biosciences, Inc. | COM | 114,554 | $158.1K | 2.8% | History |
| TRXTRX GOLD Corp | COM | 100,000 | $150.0K | 2.6% | History |
| CANFCan-Fite BioPharma Ltd. | ADR | 42,559 | $131.9K | 2.3% | History |
| SXTCChina SXT Pharmaceuticals, Inc. | USD CL A ORD SHS | 78,170 | $131.3K | 2.3% | History |
| CLDICalidi Biotherapeutics, Inc. | COM | 434,903 | $103.9K | 1.8% | History |
| BJDXBluejay Diagnostics, Inc. | COM | 28,726 | $52.9K | 0.9% | History |
| LYRALyra Therapeutics, Inc. | COM NEW | 104,059 | $51.1K | 0.9% | History |
| BNBXBNB Plus Corp. | COM NEW | 13,541 | $8.67K | 0.2% | History |